Rethinking incremental hemodialysis: dissecting the statistics from the biological signals.

The TATH study informs the feasibility of twice-weekly hemodialysis in select patients. However, associated biological signals suggest underdialysis despite preserved residual kidney function. We highlight the importance of volume status and adequacy in comparator groups to truly assess the benefits and limitations of incremental dialysis strategies in modern nephrology.